Pay in 4 interest-free payments of $7.10 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Do the side effects get worse with each dose increase
Potential benefits being investigated include: Cognitive performance : Some small-scale human studies have shown mixed results on cognitive tasks among participants receiving GLP-1 receptor agonists, with no consistent pattern of improvement established in randomised trials to date Cognitive decline : Observational data from diabetes cohorts suggest that patients prescribed GLP-1 agents may experience different rates of cognitive deterioration compared to those on other diabetes medications, though causality cannot be established Dementia risk : Population-based studies have indicated a possible association between GLP-1 receptor agonist use and dementia diagnoses, though these findings require confirmation in prospective trials Neuroimaging markers : Early research is examining potential effects on brain structure and function, but definitive evidence of preservation of brain volume has not been established Important limitations and considerations: Limited human trial data : Most evidence comes from animal models or observational studies
Clinical trials have shown that 2000-3000mg daily is effective at reducing the rate of cognitive decline measured by a range of parameters
M.XuW.WalkerB.TrimbleE
